Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A p
Clinical overview of metronomic chemotherapy in breast cancer | Nature Reviews Clinical Oncology
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Metronomic chemotherapy in mbc | PPT
2020 ASCO Update on Early TNBC: Does Metronomic Capecitabine Improve DFS Following Standard Adjuvant Therapy? | VuMedi
Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial - The Breast
Total Health | VuMedi
Cancers | Free Full-Text | Metronomic Chemotherapy
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial) | Future Oncology
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept | Scientific Reports
Low-Dose Metronomic Capecitabine (Xeloda) for Treatment ofMetastatic Cholangiocarcinoma : Case Reports and Review of the Literature | Semantic Scholar
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients' T cell ferroptosis
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Elderly Woman with Triple-negative Metastatic Breast Cancer Successfully Treated with Metronomic Capecitabine | Anticancer Research
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients' T cell ferroptosis
A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer | Trials | Full Text
